Home / Technology / Spinol Medical™ Advances OctaSeal™ Into FDA Review – A Minimally Invasive, Intradiscal Annular Closure Technology Backed by Five-Year Clinical Data

Technology

Spinol Medical™ Advances OctaSeal™ Into FDA Review – A Minimally Invasive, Intradiscal Annular Closure Technology Backed by Five-Year Clinical Data

By wpadministrator

No Comments

December 16, 2025 8:27 pm

Spinol Medical™ today announced the advancement of its OctaSeal™ Annular Closure System into U.S. FDA review. OctaSeal represents a novel, tubular-based, int…

CHICAGO–(BUSINESS WIRE)–Spinol Medical™ today announced the advancement of its OctaSeal™ Annular Closure System into U.S. FDA review. OctaSeal represents a novel, tubular-based, intradiscal technology designed to close annular defects following lum… [3459 chars]

Source: Business Wire | Published: 2025-12-16T20:27:00Z

Credit: Business Wire